AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Darktrace PLC

Transaction in Own Shares Nov 1, 2023

5064_rns_2023-11-01_547a78fc-d29b-4540-9b79-2236d099b797.html

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 9421R

Darktrace PLC

01 November 2023

Darktrace plc

1 November 2023

EBT Market Purchase Programme

Darktrace plc (DARK.L) (together with its subsidiaries "Darktrace" or the "Group"), a global leader in cyber security AI, today announces that Equiniti Trust (Jersey) Limited (the "Trustee"), as Trustee of the Darktrace Employee Benefit Trust (the "EBT") will commence on or about 1 November 2023 making further market purchases of ordinary shares of £0.01 each in Darktrace ("Shares") for up to 10 million Shares (the "EBT Market Purchase Programme").

Purchases under the EBT Market Purchase Programme are for a maximum aggregate consideration of £25 million (inclusive of brokerage and dealing charges). The EBT Market Purchase Programme will complete on or before 31 December 2023, unless extended by Darktrace (subject to applicable law). Shares purchased under the EBT Market Purchase Programme will be used to satisfy existing, planned and anticipated options and awards under Darktrace's employee share schemes, or as otherwise permissible within the terms of the EBT trust deed.

Contact:

Luk Janssens - Head of Investor Relations, Darktrace

Direct: +44 7811 027918

[email protected]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSFDAFAFEDSELS

Talk to a Data Expert

Have a question? We'll get back to you promptly.